| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 01/28/2010 | US20100024047 Prion-free transgenic ungulates |
| 01/28/2010 | US20100023468 Method and apparatus for chemical genetic programming |
| 01/28/2010 | US20100022766 Biosynthetic gene cluster for the production of a complex polyketide |
| 01/28/2010 | US20100022763 Short interference RNA duplexes when introduced into mammalian cells in culture perform sequence-specific inhibition of target mRNA without inducing an interferon response; for gene silencing to treat human diseases; double stranded siRNA |
| 01/28/2010 | US20100022762 Glyphosate-tolerant 5-enolpyruvylshikimate-3-phosphate synthases |
| 01/28/2010 | US20100022760 Mutant protein |
| 01/28/2010 | US20100022756 Trimerising Module |
| 01/28/2010 | US20100022628 Alternative oxidase and uses thereof |
| 01/28/2010 | US20100022623 Methods and Compositions for the Treatment of Eye Disorders with Increased Intraocular Pressure |
| 01/28/2010 | US20100022622 Dbait and its Standalone Uses Thereof |
| 01/28/2010 | US20100022621 Construction and use of transfection enhancer elements |
| 01/28/2010 | US20100022618 Long interfering nucleic acid duplexes targeting multiple RNA targets |
| 01/28/2010 | US20100022455 Therapeutic agents comprising elastin-like peptides |
| 01/28/2010 | US20100022454 Peptides with High Affinity for the Prolactin Receptor |
| 01/28/2010 | US20100022453 NoGo Receptor 1 and Fibroblast Growth Factor Interactions |
| 01/28/2010 | US20100022432 Use of superoxide dismutases in washing and cleaning agents |
| 01/28/2010 | US20100022413 siRNA targeting Ras-related nuclear protein RAN |
| 01/28/2010 | US20100022401 Avidin-like proteins from symbiotic bacteria |
| 01/28/2010 | US20100022393 Glyphosate applications in aquaculture |
| 01/28/2010 | US20100022027 Gene 763 of phytopathogenic fungus magnaporthe grisea and use thereof for identifying fungicidal compounds |
| 01/28/2010 | US20100022006 Gamma satellite insulator sequences and their use in preventing gene silencing |
| 01/28/2010 | US20100022005 Adipose stromal stem cells for tissue and vascular modification |
| 01/28/2010 | US20100021996 Genetically Altered Anti-body Producing Cell Lines With Improved Antibody Characteristics |
| 01/28/2010 | US20100021995 Biological products |
| 01/28/2010 | US20100021991 Methods for Producing Modified Glycoproteins |
| 01/28/2010 | US20100021987 Compositions, Methods, and Kits for Enhancing Protein Expression |
| 01/28/2010 | US20100021976 Production of polyunsaturated fatty acids, novel biosynthesis genes, and novel plant expression constructs |
| 01/28/2010 | US20100021972 Method and apparatus for amplifying nucleic acids |
| 01/28/2010 | US20100021967 Alpha Factor Signal Peptide For Producing a Polypeptide |
| 01/28/2010 | US20100021966 Method for the Preparation of Growth Hormone and Antagonist Thereof Having Lower Levels of Isoform Impurities Thereof |
| 01/28/2010 | US20100021965 Protein Expression in Rodent Cells |
| 01/28/2010 | US20100021962 Use of A Plastid-Lipid Associated Protein Promoter (PAP Promoter) For Heterologous Gene Expression |
| 01/28/2010 | US20100021952 Tetrahymena bifunctional dihydrofolate reductase-thymidylate synthase deficiency and its use |
| 01/28/2010 | US20100021951 Human Brain Carboxypeptidase B |
| 01/28/2010 | US20100021935 Goodpasture Antigen Binding Protein and Its Detection |
| 01/28/2010 | US20100021931 Fluorescence based reporter construct for the direct detection of TGF-beta receptor activation and modulators thereof |
| 01/28/2010 | US20100021925 Isolation of nucleic acids on surfaces |
| 01/28/2010 | US20100021923 Method for the efficiency-corrected real-time quantification of nucleic acids |
| 01/28/2010 | US20100021921 Mutated abl kinase domains |
| 01/28/2010 | US20100021920 Mutated abl kinase domains |
| 01/28/2010 | US20100021919 Production of Polyhydroxyalkanoates From Polyols |
| 01/28/2010 | US20100021916 Microsatellite-based fingerprinting system for saccharum complex |
| 01/28/2010 | US20100021914 Oligonucleotides for modulating target rna activity |
| 01/28/2010 | US20100021912 Methods of Modulating Lipid Concentrations in Eukaryotic Cells |
| 01/28/2010 | US20100021911 Production host cell lines |
| 01/28/2010 | US20100021908 Novel 2,5-diketo-l-gluconic acid reductases and method of use |
| 01/28/2010 | US20100021905 Compositions and methods of selective nucleic acid isolation |
| 01/28/2010 | US20100021899 Method of assaying target substance in sample, aptamer molecule and method of constructing the same |
| 01/28/2010 | US20100021895 Vectors for Inducing Homozygous Mutations and Methods of Using Same |
| 01/28/2010 | US20100021612 Method for the production of fusion proteins in transgenic mammal milk |
| 01/28/2010 | US20100021587 VARIANTS OF BACILLUS sp. TS-23 ALPHA-AMYLASE WITH ALTERED PROPERTIES |
| 01/28/2010 | US20100021586 Low post-acidifying lactic acid bacteria |
| 01/28/2010 | US20100021498 Live, attenuated pneumococcal vaccine |
| 01/28/2010 | US20100021492 Moraxella catarrhalis outer membrane protein-106 polypeptide, gene sequence and uses thereof |
| 01/28/2010 | US20100021489 comprising an RNA sequence capable of specifically binding a polypeptide participating in influenza virus infection of cells |
| 01/28/2010 | US20100021484 Compositions, Methods and Kits Relating to Poxvirus Subunit Vaccines |
| 01/28/2010 | US20100021482 Novel death associated proteins, and thap1 and par4 pathways in apoptosis control |
| 01/28/2010 | US20100021477 DESIGN AND GENERATION OF HUMAN DE NOVO pIX PHAGE DISPLAY LIBRARIES |
| 01/28/2010 | US20100021473 Bispecific Ligands With Binding Specificity to Cell Surface Targets and Methods of Use Therefor |
| 01/28/2010 | US20100021470 Monoclonal antibody production by ebv transformation of b cells |
| 01/28/2010 | US20100021469 Functional role of adrenomedullin (am) and the gene related product (pamp) in human pathology and physiology |
| 01/28/2010 | US20100021468 Novel mhc class ii restricted t cell epitopes from the cancer anitgen, ny eso-1 |
| 01/28/2010 | US20100021467 Method of detecting a cancer cell by aberrant expression of a human k+ ion channel |
| 01/28/2010 | US20100021466 Antagonistic Human LIGHT-Specific Human Monoclonal Antibodies |
| 01/28/2010 | US20100021465 Boris isoforms and methods of detecting and treating disease |
| 01/28/2010 | US20100021462 Gasp1: a follistatin domain containing protein |
| 01/28/2010 | US20100021459 Polypeptide constructs for intracellular delivery |
| 01/28/2010 | US20100021453 Targeting of triacylclycerol synthase gene for tuberculosis treatment |
| 01/28/2010 | US20100021452 Compositions and methods of use for therapeutic antibodies |
| 01/28/2010 | US20100021448 I-crei meganuclease variants with modified specificity, method of preparation and uses thereof |
| 01/28/2010 | US20100021441 Mhc molecule-binding tumor-associated peptides |
| 01/28/2010 | US20100021421 Fusion proteins and methods for modulation of immune response |
| 01/28/2010 | DE112008000747T5 Transgene Pflanzen mit erhöhter Stresstoleranz und erhöhtem Ertrag Transgenic plants with increased stress tolerance and increased yield |
| 01/28/2010 | DE102008002972A1 Neues Endolysin PlyP40 Create an endolysin PlyP40 |
| 01/28/2010 | CA2768737A1 Improved vegetable oils and uses therefor |
| 01/28/2010 | CA2762118A1 Vectors for delivery of light-sensitive proteins and methods of use |
| 01/28/2010 | CA2736062A1 Triple acting antimicrobials that are refractory to resistance development |
| 01/28/2010 | CA2733218A1 Neutralizing anti-influenza a virus antibodies and uses thereof |
| 01/28/2010 | CA2732737A1 Cancer peptide therapeutics |
| 01/28/2010 | CA2732229A1 Enhancement of sirna silencing activity using universal bases or mismatches in the sense strand |
| 01/28/2010 | CA2731779A1 Rnai constructs and uses therof |
| 01/28/2010 | CA2731760A1 Pyripyropene a biosynthetic gene |
| 01/28/2010 | CA2731643A1 Fus/tls-based compounds and methods for diagnosis, treatment and prevention of amyotrophic lateral sclerosis and related motor neuron diseases |
| 01/28/2010 | CA2731547A1 The tuberculosis rv2386c protein, compositions and uses thereof |
| 01/28/2010 | CA2731509A1 Methods, systems and compositions for increased microorganism tolerance to and production of 3-hydroxypropionic acid (3-hp) |
| 01/28/2010 | CA2731388A1 Tnfsf single chain molecules |
| 01/28/2010 | CA2731256A1 Increased ethanol production in recombinant bacteria |
| 01/28/2010 | CA2730938A1 Nucleoside triphosphate derivative, nucleic acid probe, multilabeled nucleic acid probe, method for production of multilabeled nucleic acid probe, and method for detection of target nucleic acid |
| 01/28/2010 | CA2729099A1 Plants with altered root architecture, related constructs and methods involving genes encoding rep2 polypeptides and homologs thereof |
| 01/28/2010 | CA2724908A1 Novel regulatory elements |
| 01/27/2010 | EP2147977A1 Expression cassettes for regulation of expression in monocotyledonous plants |
| 01/27/2010 | EP2147976A2 Yeast and method of producing L-lactic acid |
| 01/27/2010 | EP2147975A1 Method for determination of onset risk of glaucoma |
| 01/27/2010 | EP2147974A2 Inducible transposition in transgenic organism using transposon vector |
| 01/27/2010 | EP2147973A1 Gene-disrupted strain, recombinant plasmid, transformant and method of producing 3-carboxymuconolactone |
| 01/27/2010 | EP2147970A1 Method for production of acidic substance having carboxyl group |
| 01/27/2010 | EP2147926A1 Truncated human papillomavirus type 18 l1 proteins |
| 01/27/2010 | EP2147681A1 Compositions and methods for treating lysosomal storage disease |
| 01/27/2010 | EP2147594A1 Antibody producing non-human mammals |
| 01/27/2010 | EP2147125A1 Microorganism detection method and apparatus |